Probiotic combination of L. helveticus Rosell®-52 and B. longum Rosell®-175, first to be recognized for its specific benefits in stressed healthy adults by ANVISA in Brazil
Lallemand Health Solutions is pleased to announce that its documented probiotic combination of Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175 has been recognized by the Brazilian Health Authorities for its safety and benefits in stressed healthy individuals.
The claims approved by ANVISA, the regulatory agency for health products in Brazil, are:
- “Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 may contribute
to the reduction of feelings of anxiety in healthy individuals”
- “Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 contribute to the
reduction of gastrointestinal complications such as abdominal pain and nausea/vomit brought on by light to moderate stress in healthy individuals.”
This approval follows the approval of similar claims by Health Canada’s NNHPD.
Solange Henoud, Global Regulatory Affairs Director for Lallemand Health Solutions, commented: “First, I would like to congratulate the team, given ANVISA’s rigourous requirements, receiving this approval was a huge accomplishment and success. It leaves us even more proud by being the first probiotic to be granted a specific health claim in Brazil since the regulation governing probiotics as functional foods/supplements has undergone modernization for several years.
The Rosell®-52 and Rosell®-175 probiotic combination was the first and still is the only probiotic to be formally approved by authorities in the Brain-Gut Axis area. Beyond Brazil’s rapidly growing supplement market, this recognitionfrom competent authorities, Canada and now Brazil, adds tremendous value and indicates that the scientific evidence behind this product is reliable and verifiable. Our strategy is to apply for health claims where we can receive approvals for an authority, which are very few in the world to have framework providing for this opportunity. Having already two endorsements is big and brings in itself strong substantiation in countries where the systems do not necessarly require pre-marketing approvals for probiotic supplements making claims such as, per instance, Australia and the United States ”.
Other Lallemand Health Solutions strains and combinations approved in Brazil: Lacidofil®‘and L. rhamnosus Rosell®-11.
About Lallemand Health Solutions
Backed by a rich history and 85 years of expertise in probiotic research and development, Lallemand Health Solutions offers a full line of ready-to-market probiotic formulas and helps its partners to design their own custom & complex formulations using Harmonium, Lafti® or Rosell® Probiotic strains together with our proprietary protective technologies. Because, from the lab to the shelf, Lallemand Health Solutions controls the overall manufacturing process of its products, the company can ensure customers are receiving the highest quality standard of probiotic formulation. Cooperation spells success: we provide our partners with the full support they need to develop, register, and market their products in their own market, making Lallemand Health Solutions a complete probiotic solutions provider.
Lallemand Health Solutions covers more than 60 countries across five continents and is ready to service your probiotic needs.